News About: Pharm. Industry
Who will take top KPMA post?
There has been considerable interest in selecting the next chairman of the Korea Pharmaceutical Manufacturers Association (KPMA), as the term of incumbent Uh Joon-sun, chairman of Ahngook Pharm, ends in February.
S...
Stillen’s sales in December top 6.8 billion won
Dong-A Pharma’s Stillen, Korea’s homegrown anti-ulcerant medicine, recorded 6.8 billion won in sales last December, a 31 percent jump from 2007, leading the domestic market, according to Ubist.
The market’s second ...
Peluvi fares well in analgesic/anti-inflammatory market
Daewon Pharm is enjoying brisk sales of its new nonsteroidal anti-inflammatory drug (NSAID), Peluvi (felubiprofen).
Sales of Daewon’s felubiprofen reached over 2.0 billion won since its release in October 2008, mak...
One Wyeth, seeking dream and hope
Wyeth Korea held its vision workshop at Hotel Lotte on January 22, with a theme titled “One Wyeth, seeking dream and hope”.
All employees participated in the workshop for more harmonious relations between labor-man...
KFDA okayed 399 clinical trials in 2008
The Korea Food and Drug Administration approved a total of 399 clinical trials last year, up 177 cases compared with 282 clinical trials in 2007.
According to the KFDA, the number of multinational clinical trials c...
FTC urged to approve new regulatory guidelines
The Korea Pharmaceutical Manufacturers Association has called for the Fair Trade Commission to approve its revised version of regulatory guidelines.
The revised guidelines include regulations against undue rebates ...
Janssen Korea targets 210 billion won sales
Janssen Korea has set a goal of 210 billion won in sales this year, with its ambitious plan to launch four new drugs, such as Intelence, Jurnista, Invega and Yondelis.
- Intelence (etravirine) is a drug used for th...
Global management, R&D to drive up Daewoong
If global expansion topped Daewoong Pharm's growth strategy this year, the company’s fresh aim is to strengthen its position overseas and widen research and development in the life sciences industry.
Daewoong esta...
Samjin launches donepezil tabletsSamjin Pharm said it has launched Neutoin (donepezil) for treatment of Alzheimer’s disease.
Donepezil is used to increase cortical acetylcholine. It has an oral bioavailabili...
|
Shinpoong breaks ground for cephalosporin plant
A ground-breaking ceremony for construction of a new cephalosporin plant was held in Osung complex of North Chungcheong Province on January 16, according to Shinpoong Pharm.
The company said it will invest 33.0 bil...
